Business Context and Reporting Period
This Form 8-K is filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on October 1, 2015. The report discloses the issuance of a press release regarding financial performance for the third fiscal quarter ended September 30, 2015, and the posting of an updated investor presentation.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves solely as a notification that such information was released to the public via a press release and an updated investor presentation.
Guidance, Outlook, and Risks
- Disclosure Status: The information in Item 2.02 and Item 7.01, including the attached exhibits, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Forward-Looking Statements: The company undertakes no duty or obligation to publicly update or revise the information contained in the investor presentation, though it may do so as management deems warranted.
- Usage: The investor presentation may be used in conversations with analysts and investors.
Investor Verification Checklist
- Verify the specific financial results for the quarter ended September 30, 2015, by reviewing Exhibit 99.1 (Press Release).
- Review Exhibit 99.2 (Investor Presentation) for updated strategic outlook and operational details.
- Confirm the registrant name is MRI Interventions, Inc., as the input metadata incorrectly listed Clearpoint Neuro, Inc.
- Note that the financial data in this 8-K is not legally "filed" under Section 18 of the Exchange Act.